SeoMCP is currently in public beta. Some results may be incomplete or delayed.

takeda.com

Backlink analytics and domain authority

Backlinks
All Dofollow Nofollow UGC DR ▾ Ref. domains ▾
+ Add filter
50 backlinks All New Lost
Referring page DR Ref. domains Linked domains Anchor and target URL
gastrorecife.com.br
https://gastrorecife.com.br/
gastrorecife.com.br
0 25
(no anchor)
https://www.takeda.com/pt-br/%20
DOFOLLOW
bronchoskopie
https://www.ig-endoskopie.at/bronchoskopie
ig-endoskopie.at
13 1 98
Takeda Logo
https://www.takeda.com/
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Our Commitment to the Planet
https://www.takeda.com/corporate-responsibility/sustainable-value-report/planet
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Values and Corporate Governance
https://www.takeda.com/who-we-are/corporate-governance
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Takeda’s Global CSR Program
https://www.takeda.com/corporate-responsibility/global-csr-program
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Healthcare for all
https://www.takeda.com/our-stories/caring/healthcare-for-all
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Diversity, Equity and Inclusion
https://www.takeda.com/corporate-responsibility/sustainable-value-report/people/diversity-equity--inclusion
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Our Products
https://www.takeda.com/science/products
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Takeda Manufacturing - 2021 Facilities of the Year
https://www.takeda.com/newsroom/newsreleases/2021/takeda-manufacturing-facilities-in-japan-and-ireland-recognized-with-category-awards-for-2021-facilities-of-the-year
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Takeda Breaks Ground on its First Zero Energy Building
https://www.takeda.com/newsroom/newsreleases/2021/takeda-breaks-ground-on-its-first-zero-energy-building-in-singapore
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Innovators in Science Award Winners
https://www.takeda.com/newsroom/newsreleases/2020/takeda-and-the-new-york-academy-of-sciences-announce-2020-innovators-in-science-award-winners
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Corporate Responsibility
https://www.takeda.com/corporate-responsibility
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Takeda’s Position on Climate Change
https://www.takeda.com/4ab3a2/siteassets/system/who-we-are/companyinformation/positions--guidelines/takeda_position_climate_change_2020.pdf
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Terms of Use
https://www.takeda.com/terms-and-conditions
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
TAKEDA.COM
https://www.takeda.com/
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Takeda in the US
https://www.takeda.com/en-us/who-we-are/company-information/company-facts
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Takeda Acquires Adaptate Therapeutics
https://www.takeda.com/newsroom/newsreleases/2022/takeda-to-acquire-adaptate-biotherapeutics
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Takeda Global Headquarters
https://www.takeda.com/who-we-are/Takeda-Global-Headquarters/design-concept
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
How We Partner
https://www.takeda.com/what-we-do/alliances-partnerships
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Privacy Policy
https://www.takeda.com/privacy-notice
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Our R&D Pipeline
https://www.takeda.com/what-we-do/research-and-development/our-pipeline
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Loni's Data Science Story
https://www.takeda.com/our-stories/all-stories
DOFOLLOW
health-economics-and-outcomes-fellowship
https://jobs.takeda.com/health-economics-and-outcomes-fellowship
jobs.takeda.com
61 39 22
Takeda Unveils Newly Renovated Cambridge Building
https://www.takeda.com/en-us/our-stories/takeda-unveils-newly-renovated-building-at-500-kendall-street
DOFOLLOW
aktuelle-projekte
https://ortner-group.com/unternehmen/forschung-entwicklung/aktuelle-projekte?T=1&cHash=fb68fe579ceb86c95539b8dff28e2907
ortner-group.com
49 9 81
Takeda Logo
https://www.takeda.com/de-at
DOFOLLOW
telegram-seo-linkk-mass-backlinking-black-seo
https://hielosdelsur.cl/telegram-seo-linkk-mass-backlinking-black-seo
hielosdelsur.cl
7 2 270
TELEGRAM @SEO_LINKK – MASS BACKLINKING, HIGH-QUALITY BACKLINKS
https://www.takeda.com/our-impact/our-stories/preserving-the-1500-year-old-hollyhock-festival-in-japan
NOFOLLOW
labline
https://ortner-group.com/en/products/labline?T=3&cHash=65d880b678e699ad21b036e6bb3def78
ortner-group.com
49 9 81
Takeda Logo
https://www.takeda.com/de-at
DOFOLLOW
newborn-screening---generation-study
https://www.ttpnetwork.org.uk/resources/newborn-screening---generation-study
ttpnetwork.org.uk
57 7 63
Company logo
https://www.takeda.com/
DOFOLLOW
1370
https://www.oegmbt.at/component/k2/item/1370?fid=16
oegmbt.at
52 22 214
takeda.com
http://takeda.com/
DOFOLLOW
colourup4rare.com
https://www.colourup4rare.com/
colourup4rare.com
11 6 38
Takeda
https://www.takeda.com/de-de
DOFOLLOW
voulais-travailler-mais-ne-pouvais
https://www.crohn-larectocoliteetnous.be/voulais-travailler-mais-ne-pouvais
crohn-larectocoliteetnous.be
59 3 19
(no anchor)
https://www.takeda.com/
DOFOLLOW
list-201905
https://iyakunews.com/list-201905
iyakunews.com
7 1 1,345
武田湘南(リサーチ)サイト開設について
https://www.takeda.com/ja-jp/announcements/2019/shonanresearch
DOFOLLOW
list-201905
https://iyakunews.com/list-201905
iyakunews.com
7 1 1,345
欧州内分泌学会2019年年次総会における 慢性副甲状腺機能低下症の長期的な合併症についての新たなデータ発表について
https://www.takeda.com/jp/newsroom/newsreleases/2019/20190515-8068
DOFOLLOW
list-201905
https://iyakunews.com/list-201905
iyakunews.com
7 1 1,345
「中等症から重症の活動期のクローン病」に対する「エンタイビオ®」の 製造販売承認事項一部変更承認の取得について
https://www.takeda.com/jp/newsroom/newsreleases/2019/20190522-8073
DOFOLLOW
list-201905
https://iyakunews.com/list-201905
iyakunews.com
7 1 1,345
人事異動および機構改革について
https://www.takeda.com/jp/newsroom/newsreleases/2019/20190521-8072
DOFOLLOW
list-201905
https://iyakunews.com/list-201905
iyakunews.com
7 1 1,345
第15回国際骨髄異形成症候群シンポジウムにおける当社のオンコロジー研究に関する最新データの発表について
https://www.takeda.com/jp/newsroom/newsreleases/2019/20190509-8060
DOFOLLOW
list-201905
https://iyakunews.com/list-201905
iyakunews.com
7 1 1,345
2019年米国臨床腫瘍学会年次集会および欧州血液学会学術集会における当社の多様なオンコロジーポートフォリオおよびパイプラインに関する最新データの発表について
https://www.takeda.com/jp/newsroom/newsreleases/2019/20190517-8070
DOFOLLOW
list-201905
https://iyakunews.com/list-201905
iyakunews.com
7 1 1,345
大阪工場における前立腺がん・閉経前乳がん治療剤「リュープリン®」の新たな製造施設の建設開始について
https://www.takeda.com/ja-jp/announcements/2019/2
DOFOLLOW
list-201905
https://iyakunews.com/list-201905
iyakunews.com
7 1 1,345
潰瘍性大腸炎を対象とした2つの生物学的製剤を初めて直接比較し、ベドリズマブがアダリムマブに対し52週時点で有意に高い臨床的寛解を達成したVARSITY試験からの探索的データを 米国消化器病週間(DDW)2019において発表
https://www.takeda.com/jp/newsroom/newsreleases/2019/20190520-8071
DOFOLLOW
list-201905
https://iyakunews.com/list-201905
iyakunews.com
7 1 1,345
“Senior Short Term Loan Facility Agreement”(以下、「ショートタームローン契約」)の 借換えの実行及びハイブリッド社債(劣後特約付社債)の条件決定に関するお知らせ
https://www.takeda.com/jp/newsroom/newsreleases/2019/20190531-8074
DOFOLLOW
list-201905
https://iyakunews.com/list-201905
iyakunews.com
7 1 1,345
XiidraのNovartis社への譲渡およびTachoSilのEthicon社への譲渡について
https://www.takeda.com/jp/newsroom/newsreleases/2019/20190509-8061
DOFOLLOW
list-201905
https://iyakunews.com/list-201905
iyakunews.com
7 1 1,345
第143回定時株主総会に提案する取締役候補者について
https://www.takeda.com/jp/newsroom/newsreleases/2019/20190514-8064
DOFOLLOW
list-201905
https://iyakunews.com/list-201905
iyakunews.com
7 1 1,345
米国食品医薬品局(FDA)が、中等症から重症の活動期潰瘍性大腸炎患者を対象とした維持療法に関して、 ベドリズマブ(Entyvio®)皮下注射製剤の生物学的製剤承認申請を受理
https://www.takeda.com/jp/newsroom/newsreleases/2019/20190510-8062
DOFOLLOW
list-201905
https://iyakunews.com/list-201905
iyakunews.com
7 1 1,345
2018年度(4-3月期)の連結業績および2019年度の連結業績予想について
https://www.takeda.com/jp/newsroom/newsreleases/2019/20190514-8063
DOFOLLOW
sponsors
https://managepain.ru/events/regionalnaya-nauchno-prakticheskaya-konferentsiya-/sponsors
managepain.ru
13 9 7
Takeda
https://takeda.com/ru-ru
NOFOLLOW
Kooperations-und-Lizenzvereinbarung-zwischen-Takeda-Zedir...
https://zedira.com/News/Kooperations-und-Lizenzvereinbarung-zwischen-Takeda-Zedira-und-Dr-Falk-Pharma-zur-Entwicklung-einer-First-in-Class-Therapie-fuer-die-Zoeliakie_144?oswsid=a17d3837aa317bf141d8093168d35096
zedira.com
51 3 28
Takeda
https://www.takeda.com/
DOFOLLOW
index.php
https://www.zhm.mk/index.php?cat=58&page=182
zhm.mk
0 12
(no anchor)
https://www.takeda.com/
DOFOLLOW
colourup4rare.com
https://www.colourup4rare.com/?utm_campaign=landingpage-ch&utm_medium=referral&utm_source=ipsen
colourup4rare.com
11 6 38
Takeda
https://www.takeda.com/de-de
DOFOLLOW
list-202009
https://iyakunews.com/list-202009
iyakunews.com
7 1 1,345
2020年10月1日付 人事異動について
https://www.takeda.com/jp/newsroom/newsreleases/2020/20200918-8201
DOFOLLOW
list-202009
https://iyakunews.com/list-202009
iyakunews.com
7 1 1,345
資産売却戦略の着実な進捗を示す、欧州における一部のノン・コア資産の約5億6,200万米ドルでのCheplapharm社への譲渡について
https://www.takeda.com/jp/newsroom/newsreleases/2020/20200908-8197
DOFOLLOW
list-202009
https://iyakunews.com/list-202009
iyakunews.com
7 1 1,345
オプジーボ®とカボメティクス®の併用療法が、進行腎細胞がん患者を対象としたピボタルな第Ⅲ相CheckMate -9ER試験において有意な生存ベネフィットを示す
https://www.takeda.com/ja-jp/announcements/2020/checkmate-9er-2
DOFOLLOW
Next page →
Frequently Asked Questions
How many backlinks does takeda.com have?
The backlinks page for takeda.com shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on takeda.com. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to takeda.com dofollow or nofollow?
Backlinks to takeda.com include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.